Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
The Journal of Infectious Diseases|June 18, 2024
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older AdultsJaya Goswami, Abdullah H Baqui, Pablo A Doreski, et al.
Plos One|February 25, 2012
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Mbio|September 1, 2023
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH studyIsabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.
The Journal of Infectious Diseases|January 26, 2012
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vectorGeraldine A O'Hara, Christopher J A Duncan, Katie J Ewer, et al.
Medical Sciences (Basel, Switzerland)|February 9, 2021
COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective AnalysisKenneth F Baker, Aidan T Hanrath, Ina Schim van der Loeff, et al.
Nature Communications|December 8, 2021
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2Catherine F Hatton, Rachel A Botting, Maria Emilia Dueñas, et al.
Nature Communications|November 29, 2013
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisationKatie J Ewer, Geraldine A O'Hara, Christopher J A Duncan, et al.
Cell Reports. Medicine|April 9, 2024
Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitisKatariina Nurmi, Kristiina Silventoinen, Salla Keskitalo, et al.
The New England Journal of Medicine|December 13, 2023
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older AdultsEleanor Wilson, Jaya Goswami, Abdullah H Baqui, et al.
Pageof 13